Overview of high-risk patient screening.
Dana HADDAD
Multidisciplinary surgery planning of triple negative metastatic breast cancers.
Didier BOURGEOIS
Surgeon, Neuilly Sur Seine, France
Where do we stand in developing radionuclides against molecular markers overexpressed on breast cancer (BC) cells such as EGFR-family members?
Willy Vangu
nuclear medicine, Johannesburg, South Africa
What can incidental data bring to radiology?
Perry J. PICKHARDT
radiologist, Madison, USA
HER2-Targeted Therapies: Beyond Trastuzumab
Hassan GHAZAL